ACADIA Pharmaceuticals Inc. Profile Avatar - Palmy Investing

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the tr…
Biotechnology
US, San Diego [HQ]
ACAD/Leadership and Strategy

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ACAD's Analysis
CIK: 1070494 CUSIP: 004225108 ISIN: US0042251084 LEI: - UEI: -
Secondary Listings
ACAD has no secondary listings inside our databases.